Thermo Fisher Scientific to Up Manufacturing of Cell Therapies
Disagreements Within FDA About Novel Drug Approvals Common
Pfzier, BioNTech Select mRNA COVID-19 Vaccine Candidate
Roche’s Arthritis Drug Fails in Phase III COVID-19 Treatment Study
Pull Funding May Combat COVID-19 Vaccine Development Challenges
Members of Congress Demand Transparency of Operation Warp Speed
Pharmaceutical Mergers, Acquisitions Down in First Half of 2020
Trump Aims to Lower Drug Prices Via PBM Reform, Drug Importation
Direct-Acting Antiviral Lowers Mortality Rate Among HCV Patients
Harvard Launches Spinout to Address mRNA, CRISPR Challenges
HHS Signs $1.95B Agreement to Produce Pfizer’s COVID-19 Vaccine
GSK, CureVac Partner to Manufacture mRNA Vaccines, Antibodies
Phase 3 Clinical Trial to Study Antibody for Alzheimer’s Disease
States Sue Mallinckrodt Over Underpaid Medicaid Drug Rebates
Oxford-AstraZeneca COVID-19 Vaccine Displays Immune Response
Emergency Use Authorization Issued for COVID-19 Pooled Testing
Eli Lilly Releases Positive Phase 3 Study Results for its Antibody
Dopamine Agonist Showed No Notable Benefit in Alzheimer’s Patients
Pharma Manufacturing Industry Ranks Second in R&D Intensity
Microsoft Alliance Targets Real-Time Visibility for Supply Chains
Oxford Scientists Develop Spinout to Launch COVID-19 Rapid Test
Pfizer, BioNTech Gain FDA Fast Track for COVID-19 Vaccine Candidates
Roche to Co-Develop Investigational Therapy for RET-Altered Cancers
Pfizer Commits $100M to Help Fight Rise of Antimicrobial Resistance
Gilead Releases Additional Data on COVID-19 Antiviral, Remdesivir
HHS, DOD, Novavax Partner to Scale-Up COVID-19 Vaccine Doses
GSK, Medicago, to Develop Novel Adjuvanted COVID-19 Vaccine
Invoice-Based Drug Reimbursement Did Not Cut Medicaid Spending
Is Germany’s Drug Pricing Strategy An Option for the US?
Novartis to Pay $642M to Resolve Healthcare Fraud Allegations
Kevzara Fails in Phase 3 COVID-19 Clinical Trial
FDA Grants EUA for Becton Dickinson’s Rapid COVID-19 Antigen Test
FDA Releases Guidance on COVID-19 Vaccine Development
Judge Thwarts Biosimilar Competition For Amgen’s Enbrel
Pfizer Reports Positive Results for Potential COVID-19 Vaccine
Remdesivir’s $2,340 Price Tag Well Below Value, Gilead CEO Says
Pharmaceutical Companies Hike Drug Prices During COVID-19 Pandemic
DOJ Charges Another Generic Drug Company with Price Setting
Gilead Will Acquire Equity in Pionyr Immunotherapeutics for $275M